Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel C Baumgart

Showing results (11-20 of 126) with videos related to

Pageof 13
Sort By:
Lancet (London, England)|September 14, 2010
How many lives does an ulcerative colitis patient have?Daniel C Baumgart
Current Opinion in Investigational Drugs (London, England : 2000)|April 27, 2010
CB-01-05-MMX, a novel oral controlled-release low molecular weight heparin for the potential treatment of ulcerative colitisDaniel C Baumgart
NPJ Digital Medicine|September 14, 2020
Digital advantage in the COVID-19 response: perspective from Canada's largest integrated digitalized healthcare systemDaniel C Baumgart
Lancet (London, England)|November 6, 2007
Virchow's nodeDaniel C Baumgart, Andreas Fischer
Drug Design, Development and Therapy|January 2, 2015
Designing biologic selectivity for inflammatory bowel disease--role of vedolizumabNiklas Krupka, Daniel C Baumgart
American Family Physician|July 31, 2003
Photo quiz. Obesity and daytime sleepiness. Prader-Willi syndromeDaniel C Baumgart, Helga Gerl
Inflammopharmacology|December 30, 2011
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitisSaskia Thomas, Daniel C Baumgart
The New England Journal of Medicine|September 29, 2021
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel DiseaseDaniel C Baumgart, Catherine Le Berre
Recent Patents on Anti-Infective Drug Discovery|January 8, 2011
Viral gastroenteritis in adultsAlexander J Eckardt, Daniel C Baumgart
Lancet (London, England)|August 24, 2012
Crohn's diseaseDaniel C Baumgart, William J Sandborn
Pageof 13

Showing results (11-20 of 126) with videos related to

Sort By:
Pageof 13
Lancet (London, England)|September 14, 2010
How many lives does an ulcerative colitis patient have?Daniel C Baumgart
Current Opinion in Investigational Drugs (London, England : 2000)|April 27, 2010
CB-01-05-MMX, a novel oral controlled-release low molecular weight heparin for the potential treatment of ulcerative colitisDaniel C Baumgart
NPJ Digital Medicine|September 14, 2020
Digital advantage in the COVID-19 response: perspective from Canada's largest integrated digitalized healthcare systemDaniel C Baumgart
Lancet (London, England)|November 6, 2007
Virchow's nodeDaniel C Baumgart, Andreas Fischer
Drug Design, Development and Therapy|January 2, 2015
Designing biologic selectivity for inflammatory bowel disease--role of vedolizumabNiklas Krupka, Daniel C Baumgart
American Family Physician|July 31, 2003
Photo quiz. Obesity and daytime sleepiness. Prader-Willi syndromeDaniel C Baumgart, Helga Gerl
Inflammopharmacology|December 30, 2011
Targeting leukocyte migration and adhesion in Crohn's disease and ulcerative colitisSaskia Thomas, Daniel C Baumgart
The New England Journal of Medicine|September 29, 2021
Newer Biologic and Small-Molecule Therapies for Inflammatory Bowel DiseaseDaniel C Baumgart, Catherine Le Berre
Recent Patents on Anti-Infective Drug Discovery|January 8, 2011
Viral gastroenteritis in adultsAlexander J Eckardt, Daniel C Baumgart
Lancet (London, England)|August 24, 2012
Crohn's diseaseDaniel C Baumgart, William J Sandborn
Pageof 13